Biocon Archives - Express Pharma

Biocon announces Q3FY23 results

USFDA issues CRL for proposed biosimilar Insulin-R: Biocon

Biocon starts clinical study to evaluate efficacy of Itolizumab

‘Science 2022 Top Employer List’ recognises two Indian pharma companies

Advancements in oral dosage forms

Biocon Q4FY22 revenue at Rs 2,476 crores, up 21 per cent

Kiran Mazumdar-Shaw Elected as Fellow of Royal Society of Edinburgh

We will have to see the fine print if there is anything for pharma

Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East

Biocon gets US FDA nod for generic product